 |
Doug Macron is the editor of GenomeWeb's Gene Silencing News. He covers research and therapeutic applications of RNAi, miRNA, and other gene-silencing technologies. E-mail Doug Macron or follow his GenomeWeb Twitter account at @Genesilencing. |
Tekmira Takes Hit on Stop-Work Order Related to US Government Ebola Contract
August 09, 2012
Tekmira Takes Hit on Stop-Work Order Related to US Government Ebola Contract
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Tekmira Gets DoD Green Light to Test Improved Ebola Drug Formulation
May 9, 2013 / Gene Silencing News - Tekmira Releases Positive Interim Phase I Data on Cancer Drug, Unsure on Ebola Drug's Fate
August 16, 2012 / Gene Silencing News - Ebola Contract Drives 70 Percent Rise in Tekmira's Q1 Revenues; Supports LNP Scale-up
May 12, 2011 / Gene Silencing News - Tekmira on Track to Move Cancer Drug into Phase II, Name New Clinical Candidate in ‘13
May 16, 2013 / Gene Silencing News - Alnylam Loses Cubist as RSV Partner, Stays Focused on ATTR Programs
February 14, 2013 / Gene Silencing News